↓ Skip to main content

Antiandrogen treatments in locally advanced prostate cancer: are they all the same?

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, July 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

patent
1 patent
wikipedia
15 Wikipedia pages

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
53 Mendeley
Title
Antiandrogen treatments in locally advanced prostate cancer: are they all the same?
Published in
Journal of Cancer Research and Clinical Oncology, July 2006
DOI 10.1007/s00432-006-0133-5
Pubmed ID
Authors

David Gillatt

Abstract

The objectives are to review the published literature and to evaluate the weight of evidence for clinical effectiveness, safety, and tolerability of the currently available antiandrogens in the treatment of locally advanced prostate cancer. This article covers efficacy as monotherapy relative to castration and as adjuvant to radiotherapy and radical prostatectomy as well as adverse-effect and quality-of-life data.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 1 2%
Unknown 52 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 15%
Student > Bachelor 8 15%
Student > Master 7 13%
Student > Doctoral Student 4 8%
Researcher 4 8%
Other 9 17%
Unknown 13 25%
Readers by discipline Count As %
Medicine and Dentistry 14 26%
Nursing and Health Professions 4 8%
Agricultural and Biological Sciences 4 8%
Sports and Recreations 3 6%
Psychology 3 6%
Other 9 17%
Unknown 16 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2023.
All research outputs
#5,690,774
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#266
of 2,632 outputs
Outputs of similar age
#12,539
of 67,235 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#2
of 12 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,235 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.